Article ID Journal Published Year Pages File Type
6093355 Gastroenterology 2015 29 Pages PDF
Abstract
In KIT-mutant GIST, inhibition of PDGFRA disrupts a KIT−ERK−ETV1−KIT signaling loop by inhibiting ERK activation. The PDGFRA inhibitor crenolanib might be used to treat patients with imatinib-resistant, KIT-mutant GIST.
Related Topics
Health Sciences Medicine and Dentistry Gastroenterology
Authors
, , , , , , , , , , , , ,